India, Jan. 2 -- Recommendation to drug controller for emergency approval to India's indigenous product against COVID-19
Independent scientists and experts working with the Union government expressed concern at an expert panel's recommendation to grant emergency approval to Bharat Biotech International Limited vaccine, Covaxin, against the novel coronavirus SARS-CoV-2.
The subject expert committee (SEC) constituted by the Central Drugs Standard Control Organisation gave such a recommendation January 2, 2021 to the Drug Controller General of India, who will take the final call.
Covaxin is India's first indigenous vaccine manufactured by Bharat Biotech. Indian Council of Medical Research (ICMR) is co-sponsoring it.
The Union Ministry of H...